The point of pain in head and neck cancer.

Authors :: Bossi P
Giusti R
Tarsitano A
Airoldi M
De Sanctis V
Caspiani O
Alterio D
Tartaro T
Alfieri S
Siano M
Source :: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2019 Jun; Vol. 138, pp. 51-59. Date of Electronic Publication: 2019 Apr 05.
Publication Year :: 2019
Abstract: Head and neck cancer (HNC) can have a devastating impact on patient's lives as both disease and treatment may affect the ability to speak, swallow and breathe. These conditions limit the oral intake of food and drugs, reduce social functioning and impact on patient's quality of life. Up to 80% of patients suffering from HNC have pain due to the spread of the primary tumor, because of consequences of surgery, or by developing oral mucositis, dysphagia or neuropathy as toxic side effects of radiotherapy, chemotherapy or both. All healthcare professionals caring for HNC patients should assess palliative and supportive care needs in initial treatment planning and throughout the disease, with awareness when specialist palliative care expertise is needed. This paper focuses on assessment, characterizations and clinical management of pain in advanced HNC patients undergoing surgery, chemotherapy and radiotherapy, also underlining the importance of symptom assessment in HNC survivors and the need of clinical research in this field.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)